Nikita Shah insider trades
Open-market stock purchases and sales by Nikita Shah, Executive Vice President at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since May 7, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold | $2.6M |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $239K |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $246K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $306K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $157K |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $2.4M |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 12, 2025 | AMRX Amneal Pharmaceuticals, Inc | Sold | $1.6M |
| Nov 12, 2025 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 12, 2025 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- AMRX Amneal Pharmaceuticals, Inc: 11 sales, last Aug 12, 2026